Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study. - sprookjes - yvandenbroek - TriplyDB

Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study.

Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study.

http://www.wikidata.org/entity/Q33545445

about

Common medications used by patients with type 2 diabetes mellitus: what are their effects on the lipid profile?Acarbose: safe and effective for lowering postprandial hyperglycaemia and improving cardiovascular outcomes Postprandial hyperglycemia and endothelial function in type 2 diabetes: focus on mitiglinide Acarbose treatments improve arterial stiffness in patients with type 2 diabetes mellitus.DPP-4 inhibitor and alpha-glucosidase inhibitor equally improve endothelial function in patients with type 2 diabetes: EDGE study.Single administration of vildagliptin attenuates postprandial hypertriglyceridemia and endothelial dysfunction in normoglycemic individuals.Peripheral endothelial dysfunction is associated with gas exchange inefficiency in smokers.Comparisons of the efficacy of alpha glucosidase inhibitors on type 2 diabetes patients between Asian and Caucasian.Effect of fruit and vegetable concentrates on endothelial function in metabolic syndrome: a randomized controlled trial Influence of Acarbose on Plasma Glucose Fluctuations in Insulin-Treated Patients with Type 2 Diabetes: A Pilot Study.The effects of postprandial glucose and insulin levels on postprandial endothelial function in subjects with normal glucose tolerance.Critical evaluation of the role of acarbose in the treatment of diabetes: patient considerations.Effect of Acarbose on Long-Term Prognosis in Acute Coronary Syndromes Patients with Newly Diagnosed Impaired Glucose Tolerance.Effects of nateglinide and rosiglitazone on pancreatic alpha- and beta-cells, GLP-1 secretion and inflammatory markers in patients with type 2 diabetes: randomized crossover clinical study.Risks of cardiovascular diseases associated with dipeptidyl peptidase-4 inhibitors and other antidiabetic drugs in patients with type 2 diabetes: a nation-wide longitudinal study.Miglitol improves postprandial endothelial dysfunction in patients with acute coronary syndrome and new-onset postprandial hyperglycemia Metformin improves the angiogenic functions of endothelial progenitor cells via activating AMPK/eNOS pathway in diabetic mice Effects of low-fat dairy intake on blood pressure, endothelial function, and lipoprotein lipids in subjects with prehypertension or stage 1 hypertension Long-term effect of sitagliptin on endothelial function in type 2 diabetes: a sub-analysis of the PROLOGUE study Analysis of the add-on effect of α-glucosidase inhibitor, acarbose in insulin therapy: A pilot study On the potential of acarbose to reduce cardiovascular disease.Exercise attenuates the premature cardiovascular aging effects of type 2 diabetes mellitus.Individualized treatment of type 2 diabetes mellitus using noninsulin agents: clinical considerations for the primary care physician.Therapeutic potential of α-glucosidase inhibitors in type 2 diabetes mellitus: an evidence-based review.Insulin resistance and vascular dysfunction in chronic kidney disease: mechanisms and therapeutic interventions.Meta-analysis and critical review on the efficacy and safety of alpha glucosidase inhibitors in Asian and non-Asian populations.

P2860

Q26740253-60D02A0E-2F04-43BF-BAD2-3DE1637FE48A Q26778095-4E2BAC71-5188-4092-B527-414F0C3792DE Q26865976-A5F4009D-2E84-43D9-BBD9-734529B3C5B2 Q33588336-EBF8B509-D287-40AE-88BB-004A47215816 Q34109066-6CCBC898-FBB5-43B1-87D0-53F31E5BCD36 Q34585325-A96D792F-27D0-487B-A6C2-90910683D562 Q34980244-D7F47764-FA65-4C98-8133-BAF40E40BD19 Q35043812-1E84100B-619C-403B-99B1-F448E081E073 Q35102743-10F9E1C6-C352-42AA-BFA4-0899ADDE59A9 Q36316219-1499FCC2-CDD0-4B70-ABE2-FD0921591928 Q36316459-C3AAC24A-0639-4153-858D-2E4A95A97C37 Q36333089-10D9A9AB-1DE8-4ABC-96D0-128BE31D0893 Q36386631-0FF9DE6A-470B-425B-92AF-CB2CFD68695F Q36428446-9C5D4B53-4228-48AF-82E3-E80A47C1BA01 Q36639308-C229FB51-2538-4D57-A214-83A25E5A6C97 Q36952365-81453A47-ACF4-4ABA-984B-37219EF0856C Q37018236-557AE346-5BEA-4DFE-82DB-3ABB091FCBC2 Q37053887-5511E84F-8B8D-48DB-8C9F-0FFA9968EFA9 Q37254915-38A7BB9C-1D0B-42E0-98D7-A5B449FE40EC Q37289297-950B7F51-C161-4950-8CE2-111BFC026974 Q37717838-57395951-3EAB-42BC-9168-55988ACA60C8 Q37926770-86989408-B361-4AB4-8702-64FF886ABAFF Q38036773-57DA2DA0-BA71-42E0-AE0B-14F17A133423 Q38563239-A783B893-7A2D-4F13-806B-3F07AB799876 Q38587721-45C2E69D-3780-4674-B49E-D7CA17F20A0E Q39420555-23346EE7-8E9E-481F-BBB9-6F59B1EA06AA

P2860

Postprandial endothelial dysfunction in subjects with new-onset type 2 diabetes: an acarbose and nateglinide comparative study.

http://www.wikidata.org/entity/Q33545445

description

2010 nî lūn-bûn

@nan

2010 թուականի Մարտին հրատարակուած գիտական յօդուած

@hyw

2010 թվականի մարտին հրատարակված գիտական հոդված

@hy

2010年の論文

@ja

2010年学术文章

@wuu

2010年学术文章

@zh-cn

2010年学术文章

@zh-hans

2010年学术文章

@zh-my

2010年学术文章

@zh-sg

2010年學術文章

@yue

name

Postprandial endothelial dysfu ...... nateglinide comparative study.

@ast

Postprandial endothelial dysfu ...... nateglinide comparative study.

@en

Postprandial endothelial dysfu ...... nateglinide comparative study.

@nl

type

label

Postprandial endothelial dysfu ...... nateglinide comparative study.

@ast

Postprandial endothelial dysfu ...... nateglinide comparative study.

@en

Postprandial endothelial dysfu ...... nateglinide comparative study.

@nl

prefLabel

Postprandial endothelial dysfu ...... nateglinide comparative study.

@ast

Postprandial endothelial dysfu ...... nateglinide comparative study.

@en

Postprandial endothelial dysfu ...... nateglinide comparative study.

@nl

P1433

Q33545445-4EAF6CC1-9D87-4509-83C1-D85E46158A25

P1476

Q33545445-E66213D4-495D-4AFA-A11C-B505322E5B81

P2093

Q33545445-5B68801B-E5EE-481A-B0A4-0FA36B8B98B6

Q33545445-B9AAB937-9BA2-4599-950E-467E659231B2

Q33545445-D2153C4B-52C4-4EA9-95C6-03E26BE76CFC

P2860

Q33545445-1C54BFB4-0884-4FB5-8DCA-7341540B7E71

Q33545445-1D895F2C-A85D-4B95-B741-11E92B1FFA31

Q33545445-24F6B629-3F05-40A8-9ADF-986E3F0C2A67

Q33545445-295CAB05-E4DA-4465-AB84-112A81A05ECA

Q33545445-38E050AC-2EB1-4D34-84B5-EBD45B60DFB4

Q33545445-3CAB40B6-EC6B-4742-9D1B-91A910A7B625

Q33545445-3F353DAE-B3B7-41FE-886C-37EF90225671

Q33545445-42F430E5-3B02-402B-B2E3-E035AD93DBDA

Q33545445-6F0ABB39-8A23-4979-B36A-B9EEFE0BF9B3

Q33545445-778DC3EB-C6C4-45D1-A5B2-A4A8E11A08FA

P2888

Q33545445-80B2AE32-57D1-4296-8D84-688A179ADF0D

P304

Q33545445-FC55D0D9-C867-4EF5-AC38-E291240E9E2F

P31

Q33545445-1D750B61-A85C-4206-8574-5F349CD3C316

P356

Q33545445-0F3DA6FD-174D-4AEC-B32D-06355D4F8177

P407

Q33545445-32614C53-9D67-4E5B-AF08-59F703ED3852

P478

Q33545445-839D7B35-6300-4128-9F21-913478175B2E

P577

Q33545445-9B7A0D1D-8C88-4451-8063-843E307181EA

P5875

Q33545445-F9C6E6A5-0315-4C73-9DA0-53F092FA1CFD

P6179

Q33545445-368FC6A0-477A-4A0B-A436-27BDDD03F57A

P698

Q33545445-8740B04A-050B-4B21-8AB0-DCFA24C682D4

P921

Q33545445-0F9F62CF-D1DD-4AB5-9E65-C45D98C3E922

Q33545445-DD3A53FF-CC72-4AF4-B602-322074EAED5A

P932

Q33545445-E9518C33-6E59-4CA5-9EE6-045B945FD7C7

P356

P1433

Cardiovascular Diabetology

P1476

Postprandial endothelial dysfu ...... nateglinide comparative study.

@en

P2093

Koichi Node

http://www.w3.org/2001/XMLSchema#string

Teruo Inoue

http://www.w3.org/2001/XMLSchema#string

Toru Kato

http://www.w3.org/2001/XMLSchema#string

P2860

Homeostasis model assessment: insulin resistance and ?-cell function from fasting plasma glucose and insulin concentrations in man

Glucose tolerance and cardiovascular mortality: comparison of fasting and 2-hour diagnostic criteria.

Advantages of alpha-glucosidase inhibition as monotherapy in elderly type 2 diabetic patients.

Vascular function in Type 2 diabetes mellitus and pre-diabetes: the case for intrinsic endotheiopathy.

Impairment of endothelium-dependent dilation is an early event in children with familial hypercholesterolemia and is related to the lipoprotein(a) level.

Endothelial function: cardiac events.

Flow-mediated vasodilation as a diagnostic modality for vascular failure.

Guidelines for the ultrasound assessment of endothelial-dependent flow-mediated vasodilation of the brachial artery: a report of the International Brachial Artery Reactivity Task Force

Effects of a single administration of acarbose on postprandial glucose excursion and endothelial dysfunction in type 2 diabetic patients: a randomized crossover study.

A single dose of nateglinide improves post-challenge glucose metabolism and endothelial dysfunction in Type 2 diabetic patients.

P2888

P304

12

http://www.w3.org/2001/XMLSchema#string

P31

scholarly article

P356

10.1186/1475-2840-9-12

http://www.w3.org/2001/XMLSchema#string

P407

P478

9

http://www.w3.org/2001/XMLSchema#string

P577

2010-03-24T00:00:00Z

http://www.w3.org/2001/XMLSchema#dateTime

P5875

42540857

http://www.w3.org/2001/XMLSchema#string

P6179

1030747129

http://www.w3.org/2001/XMLSchema#string

P698

20334663

http://www.w3.org/2001/XMLSchema#string

P921

type-2 diabetes

P932

2861640

http://www.w3.org/2001/XMLSchema#string